Agency Information Collection Activities; Submission for OMB Review; Comment Request; Implementation of the Biomaterials Access Assurance Act of 1998

Özet

The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.